FDA Drug Application (016792) for SURMONTIL by ODYSSEY PHARMS

Back to FDA Applications sponsored by ODYSSEY PHARMS

Application Number016792
Product Number001
FormCAPSULE;ORAL
DosageEQ 25MG BASE
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameSURMONTIL
Active IngredientTRIMIPRAMINE MALEATE

Active IngredientCount
List of drugs with Active Ingredient TRIMIPRAMINE MALEATE2


Back to FDA Applications sponsored by ODYSSEY PHARMS